(Q34488705)

2 August 2017

title

Atrial fibrillation and stroke associated with intravenous bisphosphonate therapy in older patients with cancer (English)

1 reference

2 August 2017

1 reference

Gregg S Wilkinson

1

1 reference

2 August 2017

Jacques Baillargeon

2

1 reference

2 August 2017

Yong-Fang Kuo

3

1 reference

2 August 2017

Jean L Freeman

4

1 reference

2 August 2017

James S Goodwin

5

1 reference

2 August 2017

language of work or name

English

0 references

publication date

12 October 2010

1 reference

Journal of Clinical Oncology

2 August 2017

published in

1 reference

2 August 2017

volume

28

1 reference

2 August 2017

issue

33

1 reference

2 August 2017

page(s)

4898-4905

1 reference

Bisphosphonates and atrial fibrillation: systematic review and meta-analysis

2 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3020695

Relation of bisphosphonate therapies and risk of developing atrial fibrillation

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3020695

Use of intravenous bisphosphonates in older women with breast cancer

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3020695

Use of alendronate and risk of incident atrial fibrillation in women

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3020695

Use of bisphosphonates among women and risk of atrial fibrillation and flutter: population based case-control study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3020695

Anthracycline cardiotoxicity in breast cancer patients: synergism with trastuzumab and taxanes

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3020695

Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3020695

Narrative [corrected] review: bisphosphonates and osteonecrosis of the jaws

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3020695

Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3020695

Lifetime risk for development of atrial fibrillation: the Framingham Heart Study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3020695

Assessing comorbidity using claims data: an overview

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3020695

Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3020695

Bisphosphonates for cancer patients: why, how, and when?

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3020695

Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3020695

Impact of atrial fibrillation on the risk of death: the Framingham Heart Study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3020695

Zoledronic acid and atrial fibrillation in cancer patients.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3020695

Atrial fibrillation in fracture patients treated with oral bisphosphonates

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3020695

Alendronate and atrial fibrillation.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3020695

Coronary ischemic events after first atrial fibrillation: risk and survival.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3020695

Chemotherapy and cardiotoxicity in older breast cancer patients: a population-based study

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3020695

Cardiac morbidity of adjuvant radiotherapy for breast cancer.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3020695

Bisphosphonates induce inflammation and rupture of atherosclerotic plaques in apolipoprotein-E null mice.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3020695

Cardiotoxicity of Cancer Therapy

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3020695

Bisphosphonates and osteoporosis

9 December 2018

1 reference

12 December 2020

Accumulation of bisphosphonates in human artery and their effects on human and rat arterial function in vitro

1 reference

12 December 2020

Current use of bisphosphonates in oncology. International Bone and Cancer Study Group

1 reference

12 December 2020

Defective taxane stimulation of epirubicinol formation in the human heart: insight into the cardiac tolerability of epirubicin-taxane chemotherapies

1 reference

12 December 2020

Intravenous bisphosphonate therapy and inflammatory conditions or surgery of the jaw: a population-based analysis

1 reference

12 December 2020

Congestive Heart Failure in Older Women Treated With Adjuvant Anthracycline Chemotherapy for Breast Cancer

1 reference

12 December 2020

Identifiers

DOI

10.1200/JCO.2010.28.7524

1 reference

2 August 2017

1 reference

2 August 2017

1 reference